Critical Care Research and Practice

Critical Care Research and Practice / 2014 / Article

Research Article | Open Access

Volume 2014 |Article ID 725748 | 5 pages |

Early Critical Care Course in Children after Liver Transplant

Academic Editor: Djillali Annane
Received08 Jul 2014
Accepted15 Sep 2014
Published25 Sep 2014


Objective. To review the critical care course of children receiving orthotopic liver transplantation (OLT). Methods. A retrospective chart review of patients admitted to the pediatric critical care following OLT performed in our center between 1988 and 2011. Results. A total of 149 transplants in 145 patients with a median age of 2.7 (IQR 0.9–7) years were analyzed. Mortality in the first 28 days was 8%. The median length of stay (LOS) was 7 (4.0–12.0) days. The median length of mechanical ventilation (MV) was 3 (1.0–6.2) days. Open abdomen, age, and oxygenation index on the 2nd day predicted LOS. Open abdomen, age, amount of blood transfused during surgery, and PRISM III predicted length of MV. 28% of patients had infection and 24% developed acute rejection. In recent group (2000–2011) OLT was performed in younger patients; the risk of infection and acute rejection was reduced and patients required longer LOS and MV compared with old group (1988–1999). Conclusion. The postoperative course of children after OLT is associated with multiple complications. In recent years OLT was performed in younger children; living donors were more common; the rate of postoperative infection and suspected rejection was reduced significantly; however patients required longer MV and LOS in the PCCU.

1. Introduction

Over the past thirty years orthotopic liver transplantation (OLT) has become a standard procedure for end stage liver disease and certain metabolic diseases with a complex and challenging postoperative course [1]. Improvements in organ preservation, immunosuppression, and surgical techniques have improved survival and long term outcome of patients after OLT [24] however the early postoperative course remains challenging [5]. We conducted a retrospective chart review analysis of all patients who had undergone OLT in our center in order to report the clinical course after OLT and to capture potential changes that took place over the more recent years.

2. Materials and Methods

The study protocol was reviewed and approved by the Institutional Research Ethics Board of Western University, Ontario, Canada. Utilizing the PCCU, the pediatric liver transplant database and the hospital’s medical records, a retrospective chart review study was performed. All patients aged 1 month to 18 years old who had undergone liver transplantation during the years 1988–2011 were identified. For each of the identified patients the demographic and clinical data (pre-, intra- and postoperative) were retrieved from the chart. The following demographic data were collected: age, weight, sex, the underlying disease process, preoperative pediatric end stage liver disease (PELD) score for patient under the age of 12 years, and model for end stage liver disease (MELD) score for patients over the age of 12 years. The following intraoperative details were documented: duration of operation, graft type (living, reduced, or whole cadaver) [6, 7], closure or nonclosure of the abdominal incision, and the volume of blood and blood products infused during the surgical procedure. The following postoperative data were collected: duration of ventilation, the PRISM III [8, 9] within 12 hours of admission to the PCCU, oxygenation index (OI = FiO2MAP/PaO2), PaO2/FiO2 ratio during the first three days of ventilation, volume of blood products administered, the LOS in PCCU, and the 28 day mortality. The following complications were collected: pleural effusion, infection (culture proven), acute rejection, and intravascular thrombosis (confirmed by ultrasound and/or laparotomy). The data for the first three days of ventilation were collected from the ventilator flow sheet at approximately noontime (1000–1400) or the first data available after 6AM when the former were missing. Acute rejection was defined taking into account clinical parameters during the first 100 days [10, 11]. A number of patients required more than one transplant. A transplant that took place after discharge from the PCCU and not less than 28 days after the previous transplant was considered as a separate transplant patient.

2.1. Statistical Analysis

Statistical analysis was performed using SPSS, version 18 (SPSS, Inc., Chicago IL). Normally distributed continuous variables were reported as means with standard deviations (SD), while skewed continuous variables were described as medians with interquartile range (IQR 25–75%). Categorical data were summarized using percentages. Spearman’s rank correlation coefficient was used to assess the strength of the relationship between skewed continuous variables. The chi-square test or Fisher’s exact test was used to compare differences in proportions for categorical variables. The independent samples t-test was used to compare mean differences in normally distributed continuous variables between two groups, and the Mann-Whitney U test was used to compare skewed continuous variables between two groups. The one-way ANOVA or Kruskal Wallis test was used to compare differences in the means and medians between three groups, respectively. We also computed multiple regression models with days of ventilation and ICU days as the dependent variables. Only those variables that were significantly associated with the outcomes in the univariate analysis were included as predictor variables in the regression. A value of <0.05 was considered statistically significant.

3. Results

3.1. Baseline Characteristics

A total of 151 patients who received 161 liver transplants during 1988–2011 were identified. Six patients were excluded because of missing data or because they received bowel and liver transplant. A total of 149 transplants in 145 patients were analyzed. Eight patients underwent more than one liver transplant; 6 retransplants took place within the same admission to the PCCU. The others () took place within 38–810 days. The main reasons for retransplant were hepatic artery thrombosis and chronic rejection. The demographics are shown in Table 1.

Age (y) 4.5 ± 4.3, 2.7 (0.9–7)a
Weight (kg)16.8 ± 12.7, 11.9 (18.0–20.5)
Male (%) 80 (54)
Cadaver (%)* 98 (63)
Reduced cadaver (%)* 39 (25)
Living donor (%)* 18 (12)
PRISM on admission 8.0 ± 5.6, 7 (4–12)
PELD15.0 ± 12.5, 15 (6–24)
MELD (13 patients >12 y) 59.9 ± 25.2, 66 (59–797)
 Biliary atresia 61 (41)
 Cholestasis 20 (13)
 Fulminate hepatitis 10 (7)
 Metabolic disease 10 (7)
 Idiopathic cirrhosis 7 (5)
 Hepatoblastoma 7 (5)
 Othersb34 (23)

Median with the interquartile; bprimary and acquired etiology; *out of 155 transplants.
3.2. Length of Stay and Length of Mechanical Ventilation

The median length of stay in the PCCU was 7 days (4.0–12.0). The median length of MV was 3 days (1.0–6.2). The median length of stay in the PCCU after extubation was 3 days (2.0–5.0) days.Seventeen patients (11%) were unable to have their incision closed. They were significantly younger, with a median age of 0.9 yrs (0.6–1.4) compared to a median of 3 yrs (1.0–7.7) (). It required a median of 5.5 (4.5–8.5) days after surgery to close the incision. These patients stayed a median of 12 days (9.0–18.2) in the PCCU and received a median of 8 days (6.0–11.5) of MV compared to a median of 6 days (4.0–10.5) () and 2 days (1.0–6.0) (), respectively, in the other patients.

A multiple regression analysis for the patients who had their incision closed (close abdomen) was performed (Table 2) for all variables that were identified to correlate with the outcomes (length of mechanical ventilation or length of stay in the PCCU) in the univariate analysis.

Prediction variables Length of mechanical ventilation Length of stay in the PCCU
Beta Beta

Age −0.2*−0.278−0.203*−0.256
PELD 0.020.086
Blood trasfused in OR 0.166*0.293−0.054−0.061
PRISM 0.036*0.2020.0310.168
Infection 0.1880.170
PaO2/FiO2 first day0.000 −0.0850.000−0.036
OI second day0.436**0.396
Pleural effusion0.1620.095
Suspected rejection−0.078−0.064
Thrombosis 0.533*0.221
Creatinine postop0.0140.008

OR, operation room; OI, oxygenation index, ; .
3.3. Critical Care Course

The list of complications examined is shown in Table 3. Only one patient with a pleural effusion received a chest tube for drainage. Forty one patients (28%) had 49 infections. The most frequent source of infection was bacteremia (26/49, 53%), lungs (12/49, 24%), and abdomen (11/49, 22%). The most frequent pathogens were bacteria (79%), candida (18%), and viruses (8%). The most frequent bacteria isolated were Staphylococcus aureus, Enterococcus faecalis, and Pseudomonas aeruginosa.

Acute rejection 36 (24)
Infection 49*
Bacteremia 26
 Hepatic artery 9 (6)
 Portal vein 11 (7)
 Both 4 (3)
Pleural effusion
 Right35 (23)
 Left 3 (2)
 Bilateral 5 (3)
 Effusion with chest tube 1 (0.7)
Mortality 12 (8)

49 infections in 41 transplants, 7 patients had more than one infection.
3.4. Comparison betweeen Old Group (1988–1999) and Recent Group (2000–2011)

As shown in Table 4, there were significant differences between the old and recent group.

1988–1999 () 2000–2011 ()

Age (months) 40.5 (15–100) 17.0 (9.0–50.2)0.004
Weight (kg) 12.9 (9.4–21.6) 10.0 (7.6–18.5) 0.07
<10 kg 28.0 (30) 26.0 (43) 0.14
Living donor 5.0 (5.6) 13.0 (22) 0.005
Open abdomen (%) 5.0 (5.6) 12.0 (20) 0.001
Median PELD 14 (2–21) 15 (9–27) 0.087
Median PRISM 6.0 (4–10) 10.0 (4–13.2) 0.014
 Biliary atresia (%) 31 (34) 30 (51) 0.07
 Cholestasis (%)15 (17) 5 (8) 0.2
 Fulminant hepatitis (%) 8 (9) 2 (3) 0.3
 Metabolic disease (%) 4 (4) 6 (10) 0.3
 Hepatoblastoma (%) 2 (2) 5 (8) 0.02
Median OR time (min) 458 (398–555) 520 (520–652) 0.047
Median LOS (days) 6.0 (4–9) 8.5 (6–17)<0.001
Ventilation (days) 2.0 (1–5) 5.0 (2–10)<0.001
Ventilation (close incision) 2.0 (1–4) 4.0 (2–7) 0.003
OR blood (mL/kg) 31.0 (18–60) 54.0 (28–116) 0.002
Median first 3 days Hb (g·L−1) 108 (97–121) 93.0 (89–112) 0.007
Infection (%) 36.0 (40) 13.0 (22) 0.04
Bactermia (%) 19.0 (21) 7.0 (12) 0.02
Thrombosis (%) 13.0 (14) 11.0 (19) 0.6
Suspected rejection (%) 30.0 (33) 6.0 (10)0.002
Mortality (28 days) 6.0 (6.6) 6.0 (10.2) 0.6

4. Discussion

This study describes the early postoperative course after OLT in children in a single center. The main indication for OLT was extrahepatic biliary atresia (41%), which is similar to other reports in children [1, 12]. The majority (63%) of liver donors were cadaveric and almost half were reduced size. The use of a living donor (12%) became more common in the last two decades (Table 1) as shown by others [13]. In 22 years of OLT in children 27% took place in infants (<12 months of age) and less than 1% in neonates (<2 month). The early mortality rate within the first 28 days was 8%, consistent with other data provided in the literature [14]. Mechanical ventilation after OLT is associated with significant complications [15, 16], therefore, in the last decade a number of studies in adults [17] and children [18] have advocated for early or even immediate extubation in the operating room [17, 19, 20]. In contrast, in our institution the length of MV has increased in recent years (Table 4). This may be explained by the larger proportion of patients in whom the abdominal incision could not be closed at the time of surgery in the recent period (20%) compared to old period (5.6%) (Table 4) and to the younger age of patients in the recent group. The case series that describes early extubation in children post-OLT were mainly but not only in older children [21]. Furthermore early extubation involves different anesthetic techniques which were not used in our patients [21].

Pleural effusion was very common (28%) and right side was significantly more frequently involved. This is probably the result of a reaction to the trauma induced by retraction during surgery and placement of a foreign body in the subphrenic space, with transudation of ascitic fluid across the diaphragm [22]. Except in one case in which a chest tube was inserted, these effusions resolved spontaneously and did not affect the length of MV or LOS. Right hemidiaphragm paralysis secondary to a right phrenic nerve injury has been described but was not observed in any of our patients [5].

The major changes that took place in the recent years such as younger age of patients and more living donors (Table 4) followed the trends noted in other centers [23, 24] and likely reflect improvement in surgical techniques. Other major changes such as reduce infections, early rejection rates, and transfusion threshold were not reported previously.

Recent adult and pediatric literature suggests that RBC transfusions in the critically ill pose multiple risks [25] and restrictive transfusion practices with subnormal levels of Hgb are well tolerated by the critically ill and are associated with improved patient outcome when compared to a liberal transfusion strategy [26]. Therefore, it is expected that median Hgb in the first three days after surgery was significantly lower in the recent group (93 gL−1, 89–112) compared to the old group (108 gL−1, 97–121) (Table 4).

The relatively high incidence of infection after OLT [27] is attributed to the underlying poor medical condition, the complexity of the surgical procedure, and immunosuppression. A total of 49 infections in 41 patients (28%) is lower than the 44−74% reported by others [14, 27, 28]. The incidence of infection decreased significantly over the years from 40% in the old group to 22% in the recent group (Table 4).

The incidence of early hepatic artery thrombosis in children ranges between 15–20% and the incidence of portal vein thrombosis is usually significantly lower [29]. Our study shows a higher rate of portal vein thrombosis (11%) compared to the hepatic artery (10%). This is similar to the incidence reported by Ganschow et al. [14]. With improvement in surgical technique, fluid management, and anticoagulation monitoring and management, we expected a reduction in the incidence of vascular complications. We speculate that this was not observed in our study because in recent period patients were significantly younger (Table 4) with smaller vessels.

The prediction of LOS and length of MV after OLT has been examined in several studies in children and adults [16, 30]. In addition to the obvious increase in LOS and MV in patient whose incision could not be closed at time of surgery, a multiple regression analysis shows that LOS is affected by age and OI on the second day after surgery. Length of MV is affected by age, amount of blood administered during surgery, PRISM score, and vascular complication.

4.1. Study Limitations

This study has several limitations. It is a single center study with relatively small number of OLT. It is a retrospective study with the usual limitations associated with this type of study. Certain complications (e.g., bleeding) were not assessed because of the difficulty in assessing them in a retrospective study.

5. Conclusion

The course after OLT in the PCCU is relatively long and is associated with a relatively high rate of complications. In recent years OLT was performed in significantly younger children; living donors were more common, the transfusion threshold increased, rate of postoperative infection, and suspected rejection was reduced; However patients required significantly longer period of MV and a longer LOS in the PCCU.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Authors’ Contribution

Vinay Kukreti and Hani Daoud contributed equally.


  1. C. O. Esquivel, S. Iwatsuki, R. D. Gordon et al., “Indications for pediatric liver transplantation,” Journal of Pediatrics, vol. 111, no. 6, pp. 1039–1045, 1987. View at: Publisher Site | Google Scholar
  2. T. Yandza, F. Gauthier, and J. Valayer, “Lessons from the first 100 liver transplantations in children at Bicetre Hospital,” Journal of Pediatric Surgery, vol. 29, no. 7, pp. 905–911, 1994. View at: Publisher Site | Google Scholar
  3. S. Hadley, M. H. Samore, W. D. Lewis, R. L. Jenkins, A. W. Karchmer, and S. M. Hammer, “Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression,” Transplantation, vol. 59, no. 6, pp. 851–859, 1995. View at: Publisher Site | Google Scholar
  4. S. D. Smith, R. J. Jackson, C. J. Hannakan, R. M. Wadowsky, A. G. Tzakis, and M. I. Rowe, “Selective decontamination in pediatric liver transplants: a randomized prospective study,” Transplantation, vol. 55, no. 6, pp. 1306–1309, 1993. View at: Publisher Site | Google Scholar
  5. S. Garcia, F. Ruza, M. Gonzalez et al., “Evolution and complications in the immediate postoperative period after pediatric liver transplantation: our experience with 176 transplantations,” Transplantation Proceedings, vol. 31, no. 3, pp. 1691–1695, 1999. View at: Publisher Site | Google Scholar
  6. A. Mehrabi, H. Fonouni, S. A. Müller, and J. Schmidt, “Current concepts in transplant surgery: liver transplantation today,” Langenbeck's Archives of Surgery, vol. 393, no. 3, pp. 245–260, 2008. View at: Publisher Site | Google Scholar
  7. M. Uribe, A. Alba, B. Hunter et al., “Chilean experience in liver transplantation for acute liver failure in children,” Transplantation Proceedings, vol. 42, no. 1, pp. 293–295, 2010. View at: Publisher Site | Google Scholar
  8. C. L. Carroll, D. M. Goodman, R. A. Superina, P. F. Whitington, and E. M. Alonso, “Timed Pediatric Risk of Mortality Scores predict outcomes in pediatric liver transplant recipients,” Pediatric Transplantation, vol. 7, no. 4, pp. 289–295, 2003. View at: Publisher Site | Google Scholar
  9. M. M. Pollack, K. M. Patel, and U. E. Ruttimann, “PRISM III: an updated pediatric risk of mortality score,” Critical Care Medicine, vol. 24, no. 5, pp. 743–752, 1996. View at: Publisher Site | Google Scholar
  10. M. Robin, R. Porcher, R. De Castro et al., “Initial liver involvement in acute GVHD is predictive for nonrelapse mortality,” Transplantation, vol. 88, no. 9, pp. 1131–1136, 2009. View at: Publisher Site | Google Scholar
  11. W. M. Leisenring, P. J. Martin, E. W. Petersdorf et al., “An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens,” Blood, vol. 108, no. 2, pp. 749–755, 2006. View at: Publisher Site | Google Scholar
  12. J.-B. Otte, J. de Ville de Goyet, R. Reding et al., “Sequential treatment of biliary atresia with Kasai portoenterostomy and liver transplantation: a review,” Hepatology, vol. 20, no. 1, pp. 41S–48S, 1994. View at: Google Scholar
  13. R. Ciria, J. M. Sánchez-Hidalgo, J. Briceño et al., “Establishment of a pediatric liver transplantation program: experience with 100 transplantation procedures,” Transplantation Proceedings, vol. 41, no. 6, pp. 2444–2446, 2009. View at: Publisher Site | Google Scholar
  14. R. Ganschow, D. Nolkemper, K. Helmke et al., “Intensive care management after pediatric liver transplantation: a single-center experience,” Pediatric Transplantation, vol. 4, no. 4, pp. 273–279, 2000. View at: Publisher Site | Google Scholar
  15. M. Glanemann, U. Kaisers, J. M. Langrehr et al., “Incidence and indications for reintubation during postoperative care following orthotopic liver transplantation,” Journal of Clinical Anesthesia, vol. 13, no. 5, pp. 377–382, 2001. View at: Publisher Site | Google Scholar
  16. S. Faenza, M. S. Ravaglia, M. Cimatti, A. Dante, S. Spedicato, and A. M. M. Labate, “Analysis of the causal factors of prolonged mechanical ventilation after orthotopic liver transplant,” Transplantation Proceedings, vol. 38, no. 4, pp. 1131–1134, 2006. View at: Publisher Site | Google Scholar
  17. M. S. Mandell, T. J. Stoner, R. Barnett et al., “A multicenter evaluation of safety of early extubation in liver transplant recipients,” Liver Transplantation, vol. 13, no. 11, pp. 1557–1563, 2007. View at: Publisher Site | Google Scholar
  18. S. Ulukaya, C. Arikan, S. Aydoǵdu, H. O. Ayanoglu, and Y. Tokat, “Immediate tracheal extubation of pediatric liver transplant recipients in the operating room,” Pediatric Transplantation, vol. 7, no. 5, pp. 381–384, 2003. View at: Publisher Site | Google Scholar
  19. B. H. Ferraz-Neto, E. D. Silva, R. C. Afonso et al., “Early extubation in liver transplantation,” Transplantation Proceedings, vol. 31, no. 7, pp. 3067–3068, 1999. View at: Publisher Site | Google Scholar
  20. M. S. Mandell, J. Lockrem, and S. D. Kelley, “Immediate tracheal extubation after liver transplantation: experience of two transplant centers,” Anesthesia and Analgesia, vol. 84, no. 2, pp. 249–253, 1997. View at: Publisher Site | Google Scholar
  21. S. Ulukaya, H. O. Ayanoglu, L. Acar, Y. Tokat, and M. Kilic, “Immediate tracheal extubation of the liver transplant recipients in the operating room,” Transplantation Proceedings, vol. 34, no. 8, pp. 3334–3335, 2002. View at: Publisher Site | Google Scholar
  22. R. Golfieri, E. Giampalma, A. M. M. Labate et al., “Pulmonary complications of liver transplantation: radiological appearance and statistical evaluation of risk factors in 300 cases,” European Radiology, vol. 10, no. 7, pp. 1169–1183, 2000. View at: Publisher Site | Google Scholar
  23. M. Ueda, F. Oike, Y. Ogura et al., “Long-term outcomes of 600 living donor liver transplants for pediatric patients at a single center,” Liver Transplantation, vol. 12, no. 9, pp. 1326–1336, 2006. View at: Publisher Site | Google Scholar
  24. S. S. Sundaram, E. M. Alonso, and R. Anand, “Outcomes after liver transplantation in young infants,” Journal of Pediatric Gastroenterology and Nutrition, vol. 47, no. 4, pp. 486–492, 2008. View at: Publisher Site | Google Scholar
  25. M. C. J. Kneyber, M. I. Hersi, J. W. R. Twisk, D. G. Markhorst, and F. B. Plötz, “Red blood cell transfusion in critically ill children is independently associated with increased mortality,” Intensive Care Medicine, vol. 33, no. 8, pp. 1414–1422, 2007. View at: Publisher Site | Google Scholar
  26. J. Lacroix, P. C. Hebert, J. S. Hutchison et al., “Transfusion strategies for patients in pediatric intensive care units,” The New England Journal of Medicine, vol. 356, pp. 1609–1619, 2007. View at: Google Scholar
  27. J.-C. Bouchut, D. Stamm, O. Boillot, A. Lepape, and D. Floret, “Postoperative infectious complications in paedriatric liver transplantation: a study of 48 transplants,” Paediatric Anaesthesia, vol. 11, no. 1, pp. 93–98, 2001. View at: Publisher Site | Google Scholar
  28. D. Saint-Vil, F. I. Luks, P. Lebel et al., “Infectious complications of pediatric liver transplantation,” Journal of Pediatric Surgery, vol. 26, no. 8, pp. 908–913, 1991. View at: Publisher Site | Google Scholar
  29. A. R. Mueller, K.-P. Platz, and B. Kremer, “Early postoperative complications following liver transplantation,” Best Practice & Research Clinical Gastroenterology, vol. 18, no. 5, pp. 881–900, 2004. View at: Publisher Site | Google Scholar
  30. J. Sommerauer, M. Gayle, T. Frewen et al., “Intensive care course following liver transplantation in children,” Journal of Pediatric Surgery, vol. 23, no. 8, pp. 705–708, 1988. View at: Publisher Site | Google Scholar

Copyright © 2014 Vinay Kukreti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1914 Views | 854 Downloads | 5 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.